BRUNO DA COSTA MARTINS

(Fonte: Lattes)
Índice h a partir de 2011
13
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Faculdade de Medicina - Médico

Resultados de Busca

Agora exibindo 1 - 10 de 11
  • conferenceObject
    Magnifying Chromoendoscopy Is Decisive to Define Management of Colorectal Neoplastic Lesions
    (2015) KAWAGUTI, Fabio S.; PENNACCHI, Caterina; MARTINS, Bruno C.; RETES, Felipe A.; MARQUES, Carlos Frederico S.; NAHAS, Caio Sergio R.; SAFATLE-RIBEIRO, Adriana V.; RIBEIRO, Ulysses; NAHAS, Sergio C.; MALUF-FILHO, Fauze
  • article 3 Citação(ões) na Scopus
    Endoscopic hemostasis of a bleeding gastric gastrointestinal stromal tumor (GIST) with endoloop placement
    (2015) RETES, Felipe Alves; MARTINS, Bruno da Costa; SORBELLO, Mauricio Paulin; SATO, Cezar Fabiano Manabu; KAWAGUTI, Fabio Shiguehissa; MALUF-FILHO, Fauze; RIBEIRO-JUNIOR, Ulysses
  • article 1 Citação(ões) na Scopus
    Endoscopic stent for treatment of esophagojejunostomy fistula
    (2015) RAMOS, Marcus Fernando Kodama Pertille; MARTINS, Bruno da Costa; ALVES, Aline Marcilio; MALUF-FILHO, Fauze; RIBEIRO-JÚNIOR, Ulysses; ZILBERSTEIN, Bruno; CECCONELLO, Ivan
  • article 4 Citação(ões) na Scopus
    Underwater endoscopic resection of a neuroendocrine rectal tumor
    (2015) KAWAGUTI, Fabio Shiguehissa; OLIVEIRA, Joel Fernandez de; MARTINS, Bruno da Costa; SORBELLO, Mauricio P.; RETES, Felipe Alves; RIBEIRO, Ulysses; MALUF-FILHO, Fauze
  • article 13 Citação(ões) na Scopus
    Endoscopic radial incision and cutting procedure for a colorectal anastomotic stricture
    (2015) KAWAGUTI, Fabio Shiguehissa; MARTINS, Bruno da Costa; NAHAS, Caio Sergio Rizkallah; MARQUES, Carlos Frederico Sparapan; RIBEIRO, Ulysses; NAHAS, Sergio Carlos; MALUF-FILHO, Fauze
  • bookPart 0 Citação(ões) na Scopus
    Endoscopic therapeutic options for type 2 diabetes
    (2015) MOURA, E. G. H. De; ORSO, I. R. B.; MARTINS, B. C.; LOPES, G. S.
    The global obesity epidemic is expected to worsen with a concomitant increase in the comorbid conditions. Obesity is a major risk factor for type 2 diabetes, and it is not surprising that the global prevalence of this disease continues to increase. Given the emerging role of endoscopic procedures in the treatment of obesity and rapid changes in endoscopic technologies and techniques, this review considers the current state of endoscopic management of obesity and type 2 diabetes. Endoluminal interventions performed entirely through the gastrointestinal tract by using endoscopic devices offer the potential for an outpatient weight loss procedure that may be safer, less invasive, and more cost-effective, compared to current surgical approaches. Endoscopic techniques attempt to mimic some of the anatomic features of bariatric surgery and rely on gastric restriction and/or duodenal exclusion. In this chapter we will describe the two endoscopic methods that have much endorsement of the literature in relation to type 2 diabetes and are in current clinical use-the intragastric balloon and the duodenojejunal bypass liner. © Springer International Publishing Switzerland 2015.
  • article 5 Citação(ões) na Scopus
    Strongyloides stercoralis hyperinfection: an unusual cause of gastrointestinal bleeding
    (2015) RIOS, Juliana Trazzi; FRANCO, Matheus Cavalcante; MARTINS, Bruno da Costa; BABA, Elisa Ryoka; SAFATLE-RIBEIRO, Adriana Vaz; SAKAI, Paulo; RETES, Felipe Alves; MALUF-FILHO, Fauze
    Strongyloidiasis is a parasitic disease that may progress to a disseminated form, called hyperinfection syndrome, in patients with immunosuppression. The hyperinfection syndrome is caused by the wide multiplication and migration of infective larvae, with characteristic gastrointestinal and/or pulmonary involvement. This disease may pose a diagnostic challenge, as it presents with nonspecific findings on endoscopy.
  • conferenceObject
    Self-Expanding Metallic Stents for the Treatment of Malignant Colorectal Obstruction Are Effective and Safe
    (2015) MARTINS, Bruno C.; FRANCO, Matheus C.; RIOS, Juliana T.; KAWAGUTI, Fabio S.; LIMA, Marcelo S.; SAFATLE-RIBEIRO, Adriana V.; SORBELLO, Mauricio P.; PENNACCHI, Caterina; RETES, Felipe A.; UEMURA, Ricardo S.; GUSMON, Carla C.; GEIGER, Sebastian N.; BABA, Elisa R.; MARQUES, Carlos Frederico S.; RIBEIRO, Ulysses; NAHAS, Sergio C.; MALUF-FILHO, Fauze
  • article 35 Citação(ões) na Scopus
    Effects of Duodenal-Jejunal Bypass Liner (EndoBarrierA (R)) on Gastric Emptying in Obese and Type 2 Diabetic Patients
    (2015) MOURA, Eduardo Guimaraes Hourneaux de; LOPES, Guilherme Sauniti; MARTINS, Bruno da Costa; ORSO, Ivan Roberto Bonotto; COUTINHO, Artur Martins Novaes; OLIVEIRA, Suzana Lopes de; SAKAI, Paulo; GALVAO-NETO, Manoel dos Passos; SANTO, Marco Aurelio; SAPIENZA, Marcelo Tatit; CECCONELLO, Ivan; BUCHPIGUEL, Carlos Alberto
    The duodenal-jejunal bypass liner (DJBL) is a promising technique for treating obesity and type 2 diabetes mellitus (T2DM). However, despite promising results, its mechanism of action has not been elucidated. It is thought to promote changes in gastric emptying owing to the neuro-endocrine axis. The aim of this paper was to study DJBL-induced changes in gastric emptying and the relationship of those changes with weight loss and T2DM. Twenty-five patients with obesity and T2DM met inclusion criteria. Scintigraphic gastric emptying testing was performed prior to implantation, 16 weeks after implantation, and 4 weeks after removal. The average gastric retention was compared between tests, to examine the relationship between gastric emptying and those who lost more than 10 % of total body weight. Similarly, we compared average gastric retention between those who achieved a glycated hemoglobin target lower than 7 %. Average gastric retention was greater after DJBL implantation compared with the baseline (first hour, 74 +/- 16.3 %, p = 0.001; second hour, 45 +/- 25 %, p < 0.001; fourth hour, 15.8 +/- 15 %, p < 0.001). There was no difference between the baseline and 4 weeks after device removal (fourth hour, p = 0.057). Gastric retention was similar between patients who achieved T2DM control and those who did not (p = 0.73). Additionally, no difference was seen between patients who lost more than 10 % of body weight and those who did not (p = 0.275). DJBL delays gastric emptying but is reversible after withdrawal. The changes in gastric emptying have no relationship to weight loss and T2DM control.
  • bookPart
    Tratamento endoscópico da obesidade
    (2015) MOURA, Eduardo Guimarães Hourneaux; ORSO, Ivan Roberto Bonotto; MARTINS, Bruno da Costa; SAUNITI, Guilherme; MOURA, Diogo Turiani Hourneaux de